SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-147301
Filing Date
2023-05-18
Accepted
2023-05-17 21:32:03
Documents
21
Period of Report
2023-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d499270d8k.htm   iXBRL 8-K 41116
2 EX-5.1 d499270dex51.htm EX-5.1 6812
3 EX-10.1 d499270dex101.htm EX-10.1 1572098
4 EX-10.2 d499270dex102.htm EX-10.2 176431
5 EX-99.1 d499270dex991.htm EX-99.1 4459
9 GRAPHIC g499270dsp1.jpg GRAPHIC 4184
10 GRAPHIC g499270dsp2.jpg GRAPHIC 10673
11 GRAPHIC g499270dsp3.jpg GRAPHIC 2465
12 GRAPHIC g499270g0516090057519.jpg GRAPHIC 4498
13 GRAPHIC g499270g0517220915468.jpg GRAPHIC 2887
  Complete submission text file 0001193125-23-147301.txt   2328626

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ebs-20230515.xsd EX-101.SCH 2874
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20230515_lab.xml EX-101.LAB 17994
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20230515_pre.xml EX-101.PRE 11278
15 EXTRACTED XBRL INSTANCE DOCUMENT d499270d8k_htm.xml XML 3356
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 23933566
SIC: 2834 Pharmaceutical Preparations